Furthermore, PD-L1 expression in cancer also enhances PD-L1-mediated tumor immune resistance from cytotoxic cluster of differentiation (CD)8 T-cells through the PD-1/PD-L1 blockade [82]. Here, PDCD1 is linked to neoplasm.